ResearcherLund UniversityActive in the last 2 years
Margareta Heby
Matched on ORCID iD 0000-0001-7112-1502; OpenAlex author ID A5088592069. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4
- Trials
- 1
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2016: 1 paper · 2017: none · 2018: 1 paper, 1 trial · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol. Co-author DOI 10.1186/s12893-025-02983-w↗
- Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma. Co-author DOI 10.1002/ijc.32945↗
- Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification. Co-author DOI 10.18632/oncotarget.23486↗
- Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer. Co-author DOI 10.3109/0284186x.2015.1075663↗
Trials 1
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Karin Jirström · 3 shared papers, 1 shared trial, 2016–2020 · strength 0.44
- Trial Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer NCT03724994↗
- Paper Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinom… DOI 10.1002/ijc.32945↗
- Paper Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomark… DOI 10.18632/oncotarget.23486↗
- Karin Leandersson · 1 shared paper, 1 shared trial, 2018–2020 · strength 0.29
- Jacob Elebro · 3 shared papers, 2016–2020 · strength 0.27
- Paper Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinom… DOI 10.1002/ijc.32945↗
- Paper Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomark… DOI 10.18632/oncotarget.23486↗
- Paper Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pan… DOI 10.3109/0284186x.2015.1075663↗
- Christopher Månsson · 1 shared paper, 2025 · strength 0.20
- Nils O. Elander · 1 shared paper, 2025 · strength 0.20
- Bergþór Björnsson · 1 shared paper, 2025 · strength 0.20
- Asif Halimi · 1 shared paper, 2025 · strength 0.20
- Kristina Hasselgren · 1 shared paper, 2025 · strength 0.20
- Heikki I. Huhta · 1 shared paper, 2025 · strength 0.20
- Ernesto Sparrelid · 1 shared paper, 2025 · strength 0.20
- Poya Ghorbani · 1 shared paper, 2025 · strength 0.20
- Maria Gustafsson Liljefors · 1 shared paper, 2025 · strength 0.20
- Daniel Öhlund · 1 shared paper, 2025 · strength 0.20
- Sofie Olsson Hau · 1 shared trial, 2018 · strength 0.18
- Jakob Eberhard · 2 shared papers, 2016–2018 · strength 0.15
- Paper Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomark… DOI 10.18632/oncotarget.23486↗
- Paper Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pan… DOI 10.3109/0284186x.2015.1075663↗
- Sebastian Lundgren · 1 shared paper, 2020 · strength 0.12
- Artur Mezheyeuski · 1 shared paper, 2020 · strength 0.12
- Emelie Karnevi · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.